DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Antiestrogen
Antiestrogen
Failures and Controversies of the Antiestrogen Treatment of Breast Cancer
NDA/BLA Multi-Disciplinary Review and Evaluation
A Phosphotyrosyl Peptide That Blocks Dimerization of the Human Estrogen Receptor (Estradiol/MCF-7 Cells/Tyrosine Phosphorylation/Dimerization/DNA Binding) STEVEN F
Use of Aromatase Inhibitors in Breast Carcinoma
Network-Based Characterization of Drug-Protein Interaction Signatures
Editorial.Final 10/20/06 1:39 PM Page 10
Characterization and Quantitation of Antiestrogen Binding Sites in Estrogen Receptor-Positive and -Negative Human Breast Cancer Cell Lines1
TEDX the Endocrine Disruption Exchange 211 Grand Ave, Ste. 114, P.O
Review Therapeutic Options for Management of Endometrial
Antiestrogen ICI 164,384 Reduces Cellular Estrogen Receptor Content by Increasing Its Turnover SOPHIE DAUVOIS, PAUL S
Hormorial Therapy in the Management of Premenstrual Syndrome
Fulvestrant As a Reference Antiestrogen and Estrogen Receptor
Breast Cancer Series: Hormone Therapy1 Karen C
Downloaded from Bioscientifica.Com at 10/01/2021 06:39:57AM Via Free Access 200 a E LEMUS and Others
Dydrogesterone (Duphaston®) and Its 20-Dihydro-Derivative As Selective Estrogen Enzyme Modulators in Human Breast Cancer Cell Lines
Differential Regulation by Estrogens of Growth and Prolactin Synthesis in Pituitary Cells Suggests That Only a Small Pool of Estrogen Receptors Is Required for Growth
Effects of an Antiestrogen and Estradiol on Food Intake, Body Composition, and Metabolism in Ovariectomized Rats
Pattern Alopecia During Hormonal Anticancer Therapy in Patients with Breast Cancer
Top View
Differences Between Estrogen- and Antiestrogen-Estrogen Receptor Complexes from Human Breast Tumors Identified with an Antibody Raised Against the Estrogen Receptor1
Oral Contraceptive Pills
Tamoxifen and Endometrial Cancer: a Janus-Headed Drug
White Paper Environmental Endocrine Disrtuptors and Its Potential Impacts on Public Health and the Environment in New Jersey
In Vivo Prediction of Response to Antiestrogen Treatment in Estrogen Receptor–Positive Breast Cancer
O O O Castrate Control COHP24 O (57) Abstract: Disclosed Herein Are Compositions and Methods for Modulating the Androgen Receptor
Estrogen and Antiestrogen Regulation of Cell Cycle Progression in Breast Cancer Cells
High Inhibitory Activity of a New Antiestrogen, RU 16117 (Lla-Methoxy Ethinyl Estradiol), on the Development of Dimethylbenz(A)Anthracene-Induced Mammary Tumors
Molecular Mechanism for Breast Cancer Incidence in the Women's Health Initiative
Femara® (Letrozole Tablets)
Estetrol Review: Profile and Potential Clinical Applications
PRODUCT MONOGRAPH Norethindrone Tablets, USP 0.35
The Molecular Pharmacology of Estrogen Receptor Modulators: Implications for the Treatment of Breast Cancer
A Targeted-Covalent Inhibitor of 17-HSD1 Blocks Two
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
Chloroquine Inhibits Autophagy to Potentiate Antiestrogen Responsiveness in Erþ Breast Cancer
The Uterine and Vascular Actions of Estetrol Delineate a Distinctive Profile of Estrogen Receptor a Modulation, Uncoupling Nuclear and Membrane Activation
NOLVADEX (Tamoxifen Citrate) TABLETS
WO 2016/145298 Al 15 September 2016 (15.09.2016) P O P C T
Evaluation of the Pharmacokinetic
Etablierung Hormonaler Assays Und Testung Von Extrakten, Naturstoffen Und Synthetischen Verbindungen
Progesterone Therapy in Women with Epilepsy: the Authors Declare No Financial Or Other Conflict of Interests
The Use of High-Dose Estrogens for the Treatment of Breast Cancer
Letrozole in the Treatment of Postmenopausal Women with Advanced Breast Cancer
Advances in Aromatase Inhibition: Clinical Efficacy and Tolerability in the Treatment of Breast Cancer
Estetrol Is a Weak Estrogen Antagonizing Estradiol-Dependent Mammary Gland Proliferation
Antiestrogen Treatment of Breast Cancer: an Overview1
Improvement in Dermatomyositis Rash Associated with the Use of Antiestrogen Medication
Predictors of Antiestrogen Recommendation in Women with Estrogen Receptor–Positive Ductal Carcinoma in Situ
The Antiestrogen ICI 182780 Disrupts Estrogen Receptor Nucleocytoplasmic Shuttling
Estrogenic Potential of Progestins in Oral Contraceptives to Stimulate Human Breast Cancer Cell Proliferation 1
Early-Life Exposure to the Endocrine Disruptor 17-Α-Ethinylestradiol Induces